EcoDrugPlus

Farnesyltransferase, Caax Box, Alpha

Ensembl ID : ENSNFUG00015000584
Gene Symbol: FNTA
3 Cross references
221 Possible Orthologues:

Fibroblast Growth Factor Receptor 1

Ensembl ID : ENSNFUG00015002730
Gene Symbol: FGFR1
3 Cross references
204 Possible Orthologues:

Fibroblast Growth Factor Receptor 1a

Ensembl ID : ENSNFUG00015016655
Gene Symbol: FGFR1A
1 Cross references
209 Possible Orthologues:

Fibroblast Growth Factor Receptor 2

Ensembl ID : ENSNFUG00015017390
Gene Symbol: FGFR2
3 Cross references
214 Possible Orthologues:

Fibroblast Growth Factor Receptor 3

Ensembl ID : ENSNFUG00015020241
Gene Symbol: FGFR3
1 Cross references
193 Possible Orthologues:

Fms Related Receptor Tyrosine Kinase 4

Ensembl ID : ENSNFUG00015001315
Gene Symbol: FLT4
1 Cross references
193 Possible Orthologues:

Folate Hydrolase 1b

Ensembl ID : ENSNFUG00015003697
Gene Symbol: FOLH1B
3 Cross references
339 Possible Orthologues:

Folate Receptor Beta-Like

Ensembl ID : ENSNFUG00015003995
Gene Symbol: LOC107380468
3 Cross references
436 Possible Orthologues:

Free Fatty Acid Receptor 4

Ensembl ID : ENSNFUG00015007603
Gene Symbol: FFAR4
3 Cross references
203 Possible Orthologues:

Fyn Related Src Family Tyrosine Kinase

Ensembl ID : ENSNFUG00015025170
Gene Symbol: FRK
3 Cross references
202 Possible Orthologues:

Galactosidase Alpha

Ensembl ID : ENSNFUG00015008684
Gene Symbol: GLA
3 Cross references
196 Possible Orthologues:

Galectin-3-Like

Ensembl ID : ENSNFUG00015011711
Gene Symbol: LOC107391754
3 Cross references
220 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).